` PHLI (PacificHealth Laboratories Inc) vs S&P 500 Comparison - Alpha Spread

PHLI
vs
S&P 500

Over the past 12 months, PHLI has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +33% growth.

Stocks Performance
PHLI vs S&P 500

Loading
PHLI
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
PHLI vs S&P 500

Loading
PHLI
S&P 500
Difference
www.alphaspread.com

Performance By Year
PHLI vs S&P 500

Loading
PHLI
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
PacificHealth Laboratories Inc vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

PacificHealth Laboratories Inc
Glance View

PacificHealth Laboratories, Inc. engages in developing, marketing and selling of patented premium nutrition tools that enable its consumers to enhance their health, improve their performance and reach their athletic goals. The company is headquartered in Matawan, New Jersey and currently employs 8 full-time employees. The firm's principal area of focus is sports performance. The firm develops products that enhance hydration, fueling and muscle recovery. The firm's products include Endurox R4 Muscle Recovery Drink; Accelerade Protein Powered Sports Drink; Accel Gel All Natural Rapid Energy Gel; 2nd Surge; Endurox Excel; Accelerade Variety Pack, and Water Bottle. Its products are available in various flavors, which include tangy orange, fruit punch, lemon lime, chocolate, lemonade and double expresso.

PHLI Intrinsic Value
Not Available
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett